NEW YORK (Reuters Health) – Percutaneous coronary intervention (PCI) performed via the transradial approach is less apt to cause bleeding and transfusions compared with PCI performed via the…
NEW YORK (Reuters Health) – Blood pressure lowering provides protection against intracranial bleeding in patients with cerebrovascular disease, including those on antithrombotic therapy, according to results of a…
NEW YORK (Reuters Health) – Nutritional support, mainly in the form of oral nutritional supplements, boosts protein and energy intake, body weight and grip strength in malnourished patients…
Influenza infection is a common reason children and teens are hospitalized in the United States each year. While the flu vaccine is safe and effective just over half…
Recent studies show that sales and deaths related to opiate pain relievers have quadrupled over the last decade in the United States. Also, illicit drug use among pregnant…
Nearly everyone agrees, health care costs in the United States are becoming unsustainable. These higher costs not only affect Medicare and Medicaid services but private sector health insurance…
NEW YORK (Reuters Health) – Patients with advanced non-small-cell lung cancer have higher response rates to a regimen that includes an albumin-bound formulation of paclitaxel (nab-paclitaxel) than solvent-based…
NEW YORK (Reuters Health) – In African Americans with moderate-to-severe asthma, treatment for a year with an inhaled combination of budesonide and formoterol is safe and reduces asthma…
NEW YORK (Reuters Health) – Results of a new meta-analysis indicate that for patients with atrial fibrillation, treatment with one of the new oral anticoagulants rather than warfarin…
NEW YORK (Reuters Health) – In a large randomized study of hemodialysis patients with new arteriovenous grafts, daily fish oil supplementation didn’t improve long-term graft patency. However, those…
NEW YORK (Reuters Health) – The neonate with suspected sepsis presents several challenges for clinicians, which are addressed in a newly published Clinical Report from the American Academy…
NEW YORK (Reuters Health) – For patients on maintenance prasugrel (Effient) therapy having percutaneous coronary intervention (PCI), a dose of 60 mg in the peri-PCI period achieves “faster…
